https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-design-guide-.pdf
CHAPTER 3 | PART DESIGN GUIDELINES Wall Thickness (mm) C o o li n g T im e ( S e c ) 40 35 30 25 20 15 10 5 0 0 1 2 3 4 ABS PC Nylon 6/6 Figure 2 - Designing for Wall Thickness Changes Bad Better Recommended Recommended Poor High Stress Ideal Figure 3 - Internal and External Radius Guidelines .5W Min Inside Rad + W Poor High Volume FIGURE 1 - Wall thickness vs. cooling time of various plastics FIGURE 2 - Designing for wall thickness changes FIGURE 3 - Internal and external radius guidelines Design Guide 9 RIB DESIGN GUIDELINES The minimum distance ribs should be spaced is three times the nominal wall thickness (3W).
Hoop stress can be determined using the following equations (figures 15–18).1 • V = Length of Boss (figure 14) = .400 • I = Interference Fit (figure 15) • W = Geometry Factor (figure 16) • H = Hoop Stress (figure 17) • E = Material Modulus • μ = Frictional force between materials • lEngage = length of engagement between the shaft and the hub Press Fit Example Problem Figure 14 is an example of a press fit problem.
FIGURE 32 - Bubbler (left) & Ba�e (Right) FIGURE 34 - Bubbler (left) & Baffle (right) Part FIGURE 35 - Series cooling line layout 25% - 75% Wall Thickness 10˚(soft materials) - 30˚(brittle materials) 110˚(brittle materials)- 140˚(soft materials) FIGURE 33 - Tunnel gate 18 Gravi-Tech Cooling Line Guidelines The rules for cooling line layouts are to keep the depth and pitch ratios constant throughout.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
• A reconciliation of each non‐GAAP financial measure with the most directly comparable GAAP financial measure is attached to this presentation which is co pa ab e G a c a easu e s attac ed to t s p ese tat o c s posted on our website at www.polyone.com.
Page 3 Strategy and Execution Drive Results 90% $22 $24 PolyOne Stock Price 50% 70% $18 $20 $22 S&P 500 (relative performance) 30% $12 $14 $16 S&P 500 (relative performance) ‐10% 10% $6 $8 $10 50% ‐30% $0 $2 $4 $ | ‐50%$0 2006 2007 2008 2009 2010 2011 2012 2013 Page 4 Four Pillar Strategy The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized Polymer Materials, Services & Solutions Page 5 Spartech – Compelling Strategic Rationale • Spartech expands PolyOne’s specialty portfolio with adjacent technologies in attractive end markets Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only 6% of Spartech’s revenues are outside of North America • PolyOne has a proven management team with a track record of transformational success • Preliminary synergy estimated at $65 million run rate by end of 3year 3 Significant opportunity to expand profitability by leveraging PolyOne’s four pillar strategy • Substantial potential share price appreciation for all shareholders f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once synergies realized Page 6 Mix Shift Highlights Specialty Transformation Old PolyOne Transformation 100% 2015 Target 80% In co m e* 65 – 75%40% 60% f O pe ra tin g 34% 43% 45% 65 75% 20% % o f 2%0% 2005 2008 2010 2012 2015 Specialty OI $5M $46M $87M $114M Target *Operating Income excludes corporate charges and special items JV's PP&S Distribution Specialty Page 7 Proof of Performance 2007 2012 2015 “Where we were” “Where we are” “Where we Where we were Where we are expect to be" 1) Operating Income % Specialty 3.2% 9.1% 12 – 16% PP&S 6.1% 9.0% 9 – 12% Distribution 3.0% 6.4% 6 – 7.5% 2) Specialty Platform sss% of Operating Income 20% 45% 65 – 75% 3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15% 4) Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period **4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS Page 8 Proof of Performance Spartech Opportunity Intermediate PolyOne Spartech Opportunity 2006 2012 Today Goal “Where we were” “Where we are” “Where Spartech is”* “Where we can go”were are Spartech is can go Specialty Operating Margin 1.5% 9.1% 2.2% 8.0% – 10.0% Margin Page 9 *Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012 At a Glance PolyOne Europe 14% Canada 8% Asia 5% Latin America 3% Distribution 2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion* United States 70% 14% 5% PP&S 20%Specialty 57% 23% 70% Appliance 5% Building & HealthCare Transportation 16% Textiles 2% 1.02 1.20 $1.20 $1.40 ha re End Markets* EPS Growth g Construction 14% Wire & Cable 8% Consumer 8% Packaging 17% Industrial 11% Misc. 6% 9% 0.27 0 21 0.79 $0.40 $0.60 $0.80 $1.00 Ad ju st ed E ar ni ng s P er S Electrical & Electronics 4% 0.12 0.21 0.13 $0.00 $0.20 2006 2007 2008 2009 2010 2011 2012 Page 10 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms At a Glance Specialty U it d 2012 Revenues: $2.4 Billion* Solutions United States 59% Europe 23% Asia Canada 4% Asia 9% Latin America 5% Appliance 4% Building & C t ti HealthCare 5% Transportation 16% Textiles 2% % o f S al es 12-16% End Markets* Expanding Profits Construction 11% Wire & Cable 7% Electrical & Electronics Packaging 23% Industrial 7% Misc. 15% 1.5% 3.2% 4.3% 5.3% 8.4% 9.1% O pe ra tin g In co m e % 8.0% Electronics 4% Consumer 6% Page 11 2006 2007 2008 2009 2010 2011 2012 2015 O Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms At a Glance Designed Structures and Solutions United States 2012 Revenues: $0.85 Billion* Solutions 84% Europe 2% Canada 7% Latin America 7% Appliance 4% Building & Construction 11% Wire & Cable Sign & Advertising 3% Recreation & Leisure 2% Pool & Spa 1% Distribution & Thermoform 8% Textiles 2% Operating Income % of Sales 2012 Revenue by Industry Segment* Expanding Profits** Wire & Cable 7% Electrical & Electronics 4% Consumer 6% Packaging 23%Industrial 7% Transportation 16% 3% 2.2% 8 ‐ 10% 7% Misc. 1% HealthCare 5% 2012 2015 Target Page 12 *Pro Forma includes FY2012 results for Spartech (11/03/12 YE) **Pro Forma results include Spartech corporate allocations for FY12 Positioned for Earnings Growth 2015 Target Rev: $5B Adj.
https://www.avient.com/sites/default/files/2024-05/AVNT Q1 2024 Investor Presentation_website w Non-GAAP.pdf
Microsoft PowerPoint - AVNT Q1 2024 Investor Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) M AY 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great Place to Work® culture Strategic ObjectivesStrategic Objectives Long Term Growth Rates Growth DriversGrowth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable GrowthProfitable Growth Great Place to WorkGreat Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- M AY 7 , 2024 W EB CAS T P RE SE N TATI O N 7 REGIONAL DEMAND TRENDS-TOTAL COMPANY Q 1 S A L E S V S P Y ( E X C L U D I N G F X ) 7 US & Canada Latin America EMEA Asia +2% -6% Flat +2% Avient ex.
https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
Microsoft PowerPoint - AVNT M11 Investor Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) N OV E M B E R 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
https://www.avient.com/sites/default/files/2022-10/Omnicolor Case Study Plastic Molder.pdf
PLASTIC INJECTION MOLDER V A R I O U S M A R K E T S & A P P L I C A T I O N S • Ability to use a color concentrate in multiple resins • Low let down ratio (LDR) • Color consistency over time • Offered versatile solution across resins and in various molding methods • Provided range of 1-3% LDRs in four standard colors • Achieved consistent color in a variety of products and markets for over 10 years Omnicolor™ Multipurpose Colorants KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-12/Archery Cable Guard Application Snapshot.pdf
CABLE GUARD C O M P O U N D A R C H E R Y B O W • Consistent quality that withstands extreme outdoor conditions • Dimensional stability to improve durability and extend product life • Lightweight material for easy customer handling • Strong, long-lasting quality • Maintained stiffness and straightness while upholding performance and aesthetic specifications • Provided dimensional stability necessary for outdoor applications • High strength-to-weight ratio enabled high performance without adding significant weight Glasforms™ Pultruded Carbon Fiber Rod KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-03/Application Snapshot Intraoral Scanner.pdf
SURGICAL INSTRUMENT OEM I N T R A O R A L S C A N N E R • Chemical and impact resistance • Customized pre-colored solutions • Color and dimension stable after sterilization • Minimum color deviation and easy to process • Technical support and color expertise • Offered bright white and customized pre- colored formulations in PPSU and PSU for intraoral scanner head and body parts • Provided a solution that can withstand up to 1,000 cycles autoclave, with good chemical and excellent impact resistance • Met customer request for color stability after processing and biocompatible compliance Transcend™ Premier Healthcare Colorants KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2022-10/Patient Mobility Mini Case Study.pdf
PERSONAL CARE DEVICES P A T I E N T M O B I L I T Y • Diminish the growth of harmful microbes on surfaces without compromising product performance • Achieve cohesive color across different polymeric materials with the addition of antimicrobial ingredients • Accelerate product development timeline • Preserved polymer performance by minimizing undesirable microbes • Designed a masterbatch solution that achieved color harmony between diverse polymeric materials even with the addition of antimicrobial ingredients • Accelerated speed to market by several weeks with Avient’s pre-tested material and supplier expertise while reducing costs of lab testing fees by up to $50,000 Cesa™ WithStand™ Antimicrobial Additives with OnColor™ Colorants KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-08/Hydrocerol Chemical Foaming Agents - PP Door Panel - Application Snapshot 2.pdf
AUTOMOTIVE OEM P P D O O R P A N E L • Reduce weight while maintaining exact mechanical properties • Provide a more sustainable solution • Reduce CO2 emissions in material production and in the use phase • Offered formulation expertise and a broad portfolio of solutions • Provided technical support to help with product selection and processing parameters • Achieved good surface finish • Enabled a 20% weight reduction Hydrocerol™ Chemical Foaming Agents KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2025-02/MAXXAM Living Wall Planter Application Snapshot.pdf
B&C COMPANY L I V I N G W A L L P L A N T E R • Non-halogen flame retardant formulation • SBI fire test rating of B-S2-D0 • Good durability and UV stability • Easy to process • Good cost/performance • Provided an optimal balance of fire safety and durability • Improved environmental responsibility for construction application • Supported the appealing design and surface aesthetic Maxxam NHFR Non-Halogen Flame Retardant Polyolefin Formulation KEY REQUIREMENTS WHY AVIENT?